| Vol. 9.01 – 16 January, 2023 |
| |
|
|
| The authors used a human-like mouse model of full-thickness skin excision to assess the underlying mechanisms of mucosal associated invariant T (MAIT) cell tissue repair function. [Immunity] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
| DERMAL STEM CELLS & TISSUE REGENERATION |
|
|
|
| Investigators showed that mouse primary epidermal organoids support USA300 colonization and invasion, exhibiting swollen epithelial squamous cells with nuclear necrosis and secreting inflammatory factors such as IL-1β. [Cell Death & Disease] |
|
|
|
| Scientists utilized solvent cast Q-peptide conjugated collagen-chitosan seeded with fibroblast monolayers to investigate the direct impact of the material on this major cell type in the context of wound healing. [iScience] |
|
|
|
| Immunohistochemistry and RNA in situ hybridization analysis showed a confined pyruvate kinase M (Pkm2) expression to keratinocytes of the hyperproliferative epithelium and, to a lesser extent, infiltrating neutrophils and monocytes. [Journal Of Molecular Medicine] |
| |
|
|
| Apremilast abrogated pemphigus autoantibody-induced loss of keratinocyte cohesion in ex vivo human epidermis, cultured keratinocytes in vitro and in vivo in mice. [Nature Communications] |
|
|
|
| Using in vitro and in vivo cytotoxic assays, investigators showed that NGFR protected melanoma cells from natural killer (NK) cell–mediated killing and, furthermore, boosted metastasis formation in a mouse model with adoptively transferred human NK cells. [Science Advances] |
|
|
|
| In a subset of prostate cancer organoid culture and xenograft models, inhibition of Wnt synthesis stimulated growth, while WNT5a or a WNT5a mimetic peptide markedly suppressed tumor growth. [Cancer Research] |
|
|
|
| ONCOS-207 which expressed Tissue Inhibitors of Metalloprotease type 2, ONCOS-209 which expressed peptidyl arginine deiminase, ONCOS-210 and ONCOS-212 which expressed both TIMP-2 and PADI1, exhibited oncolytic activity against four melanoma cell lines in vitro. [Molecular Therapy-Oncolytics] |
|
|
|
| PCSK9’s association with melanoma was analyzed using the TCGA dataset. Empty vector, PCSK9, gain-of-function, and loss-of-function PCSK9 mutants were stably-expressed in murine melanoma B16 cells and studied for impact on B16 cell-derived oncogenesis in vitro and in vivo. [Journal Of Experimental & Clinical Cancer Research] |
|
|
|
| Skin cells were cultivated in vitro, to isolate their characteristic autofluorescence form the more complex one that would be originated by the complete skin tissue. [Journal Of Biophotonics] |
|
|
|
|
| The authors summarize the latest knowledge about the molecular pathways and therapeutic opportunities attendant to keratinocytic skin cancers. [Cancer] |
|
|
|
|
| SFA Therapeutics, Inc.announced that it has received clearance from the US FDA to proceed with an extension to the ongoing Phase Ib clinical trial of SFA-002, an investigational drug candidate for psoriasis. [SFA Therapeutics, Inc.] |
|
|
|
| SCOHIA PHARMA, Inc. and Kuria Therapeutics announced that the US Patent Office has issued a composition-of-matter patent covering SCO-116, a novel Nrf2 activator being developed by Kuria for prevention and treatment of eye and skin diseases. [SCOHIA PHARMA, Inc] |
|
|
|
|
| February 19 – 22, 2023 Banff, Alberta, Canada |
|
|
|
|
|
| Icahn School of Medicine at the Mount Sinai Medical Center – New York, New York, United States |
|
|
|
| Bar-Ilan University – Ramat Gan, Israel |
|
|
|
| Pompeu Fabra University – Barcelona, Spain |
|
|
|
| The University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
| US FDA – Silver Spring, Maryland, United States |
|
|
|
|